Summary Keywords IBD, GLP-1, GLP-1 receptor agonists, diabetes, obesity Citation Migliorisi G, Gabbiadini R, Dal Buono A, Ferraris M, Privitera G, Petronio L, Bertoli P, Bezzio C and Armuzzi A (2025) GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
Semaglutide slows gastric emptying and commonly causes constipation and nausea
For Medicare beneficiaries who previously could not afford GLP-1 medications for weight loss, this is the first realistic path to coverage
This means it doesnt kill bacteria, but it effectively stops them from multiplying
Since it is a customized formulation, only your prescribing provider and the pharmacy can confirm the exact dosage
GLP-1 (short for glucagon-like peptide-1) is a natural hormone made in the small intestine